AMGN vs PFE — Key Metrics

Metric AMGN (AMGEN INC) PFE (PFIZER INC)
Price443.8928.06
Market Cap240.11 Billion159.94 Billion
P/E (TTM)25.5439.52
P/B (Quarterly)18.0331.921
P/S (TTM)6.172.51
Net Profit Margin (TTM)24.16.3
Gross Margin (TTM)70.973.4
ROE (TTM)85.64.6
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

AMGEN INC
vs
 
PFIZER INC
 
AMGEN INC
vs
 
PFIZER INC
Performance Comparison
AI Model Recommendation
AMGN · AMGEN INC

Outperform

38
UnderperformOutperform
PFE · PFIZER INC

Greatly Outperform

91
UnderperformOutperform
Recommendation Summary

Stock AMGN is projected to outperform the market, stock PFE is projected to greatly outperform the market. Upfront Recommendation: PFE.

Financial Metrics
Prices delayed ~15 min
AMGN Metrics PFE
$443.89 Price $28.06
— Market Capitalization —
25.54 Price to Earnings Ratio 39.52
6.17 Price to Sales 2.51
25.06 Price to FCF Ratio 13.57
8.7 Price to Gross Profit 3.43
30.63 Price to R&D 13.88
6.99 Price to Current Assets 3.55

AMGN vs PFE at a glance

Amgen INC (AMGN) and Pfizer INC (PFE) are both Drug Manufacturers - General companies in the Healthcare sector. AMGN is the larger, at $240.1 billion in market value against $159.9 billion for PFE, about 1.5 times the size.

On trailing-twelve-month figures, AMGN trades at 25.5 times trailing earnings and PFE at 39.5; net profit margins are 24.1% and 6.3%.

The Upfront Investment model currently rates AMGN Outperform and PFE Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.